INDEX — InDex Pharmaceuticals Holding AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK154.48m
- -SEK137.49m
- SEK97.51m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 127 | 53.8 | 428 | 345 | 294 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.004 | 0 | 0 | 0 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 129 | 57.8 | 443 | 347 | 297 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.475 | 3.41 | 2.16 | 3.99 | 2.77 |
Long Term Investments | |||||
Total Assets | 129 | 61.2 | 445 | 351 | 299 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.6 | 10.3 | 10.6 | 14.7 | 58.9 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.6 | 11.9 | 11.2 | 17.4 | 60.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 107 | 49.3 | 434 | 334 | 239 |
Total Liabilities & Shareholders' Equity | 129 | 61.2 | 445 | 351 | 299 |
Total Common Shares Outstanding |